2020, FDA, Food and Drug Administration and Medical science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2020

FDA

Food and Drug Administration

Medical science

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

DECEMBER 28, 2023

We received encouraging feedback from the US Food and Drug Administration (FDA) on the trial design and potential for accelerated approval. In addition, we have received Fast Track designation by the FDA in September 2023 highlighting the impact this combination treatment can have for patients.

Food and Drug Administration

Food and Drug Administration Patients Safety Medical science

Moving towards oral delivery of biologics

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. When the balloon reaches a sufficient pressure, this pushes the dissolvable needle into the intestinal wall, delivering the drug payload.”

Food and Drug Administration

Food and Drug Administration Manufacturing Safety Pharmaceutical

Pharma Rep Focus

Leveraging innate cell engagers for lymphoma treatment

Moving towards oral delivery of biologics

Stay Connected